RxDoctor Payments Data

Jessica Potter Lott, APRN

Acute Care · Salt Lake City, UTNPI 1467938936

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $819 of the $1,216 with a category attached, or 67.3%. Intuitive Surgical accounts for 68.5% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2021 at $833 and has fallen 94.8% since, to $44 in 2024.

$1,216in general payments, 2019–2025

Across 15 payments — averaging $81.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$833
  • Medical Device Business Services, Inc.$137
  • Novartis$44
  • Zimmer Biomet$43
  • Getinge USA Sales, LLC$43
  • Merck$32
  • plus $84 from 4 others

What the payments were for

  • Travel & lodging$81967%
  • Food & beverage$26021%
  • Education$13711%

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,216 in reported general payments places this provider in the 85th percentile of 119 acute care providers in Utah.

See all acute care providers in Utah

Medicare billing

Part B allowed, 2024
$165,683
Medicare patients
198
Services billed
1,417

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban35$13,072
Lacosamide25$3,497
Fentanyl18$2,541
Gabapentin113$2,481
Oxycodone Hcl78$1,557
Diclofenac Sodium30$1,068
Pregabalin45$1,064
Methenamine Hippurate11$930
Tramadol Hcl55$723
Lantus SolostarInsulin Glargine,hum.Rec.Anlog13$629
Ondansetron Hcl24$470
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst12$418
Escitalopram Oxalate16$378
Amlodipine Besylate44$354
Tamsulosin Hcl21$330

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$23$13,07235 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 119 acute care providers in Utah.

Other acute care in Salt Lake City

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →